跳到主要內容區塊
:::
開啟
:::
  • 20230921-2
  • 演講或講座
  • 生物醫學科學研究所
  • 地點

    生醫所地下室B1C演講廳

  • 演講人姓名

    張瑋婷博士 (奇美醫院)

  • 活動狀態

    確定

  • 活動網址

A journey of two stories-- translational and mechanistic studies of Cardio-Oncology and valvular heart diseases

2023-09-21 16:00 - 17:00

加入行事曆
  1. Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis. Lin YM, Lee MC, Toh HS, Chang WT, et al. Ann Intensive Care. 2022 Dec 13;12(1):112
  2. Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan. Lin PL, Wu YW, Lin CF, Yeh HI, Chang WT, et al. J Atheroscler Thromb. 2022 Nov 24
  3. Lee MC, Hua YM, Yang CT, Kuo FH, Chang WT, et al. Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials. Medicine (Baltimore). 2022 Dec 23;101(51):e32489
  4. Chao CM, Wang LY, Huang CC, Chang WT, Tang LY, Lin MT, Chang CP. Myocardial structure and functional alterations in a preclinical model of exertional heat stroke. Life Sci. 2023 Mar 31;323:121640. 
  5. Chang WT, Sun CK, Wu JY, Huang PY, Liu TH, Chang YJ, Lin YT, Kang FC, Hung KC. Association of prognostic nutritional index with risk of contrast induced nephropathy: A meta-analysis. Front Nutr. 2023 Mar 23;10:1154409. 
  6. Chang WT, Lin HW, Lin SH, Li YH. Association of statin use with cancer- and non-cancer-associated survival in patients with breast cancer in Asia. JAMA Network Open. 2023 Apr 3;6(4):e239515 
  7. Chang WT, Lin HW, Lin SH, Li YH. The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan. Front Oncol. 2023 Apr 17;13:1172036.
  8. Chang WT, Lin HW, Chang TC, Lin SH, Li YH. Assessment of tyrosine kinase inhibitors on the survival and cardiovascular outcomes of patients with non-small cell lung cancer in Taiwan. JAMA Network Open. 2023 May 1;6(5):e2313824
  9. Lee WC, Chang WT, et al. Sodium-Glucose Cotransporter 2 Inhibitors First Strategy Improve Decongestion in Patients with Symptomatic Heart Failure and Reduced Ejection Fraction When Compared to Angiotensin Receptor Neprilysin Inhibitor First Strategy. Front Biosci (Landmark Ed). 2023 Apr 27;28(4):81.
  10. Liao CT, Toh HS, Chang WT, et al. Assessment of subclinical cardiac dysfunction by speckle-tracking echocardiography among people living with human immunodeficiency virus. Front Cardiovasc Med. 2023 May 23;10:1200418